• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CD3+CD4低表达和CD3+CD8低表达由HLA-G诱导:参与移植耐受的新型人类外周血抑制性T细胞亚群。

CD3+CD4low and CD3+CD8low are induced by HLA-G: novel human peripheral blood suppressor T-cell subsets involved in transplant acceptance.

作者信息

Naji Abderrahim, Le Rond Solene, Durrbach Antoine, Krawice-Radanne Irene, Creput Caroline, Daouya Marina, Caumartin Julien, LeMaoult Joel, Carosella Edgardo D, Rouas-Freiss Nathalie

机构信息

Service de Recherches en Hemato-Immunologie, Commissariat à l'energie atomique-Direction des science, du vivant-Departement de la recherche medical (CEA-DSV-DRM), Hopital Saint-Louis, Paris, France.

出版信息

Blood. 2007 Dec 1;110(12):3936-48. doi: 10.1182/blood-2007-04-083139. Epub 2007 Sep 5.

DOI:10.1182/blood-2007-04-083139
PMID:17804694
Abstract

HLA-G is a tolerogenic molecule whose detection in sera and within allografted tissues is associated with better graft acceptance. HLA-G mediates T-cell differentiation into suppressor cells, which are thought to promote tolerance. Here, we investigated such T cells phenotypically and functionally and assessed their clinical relevance in the peripheral blood of patients who have undergone transplantation. Our results demonstrate that HLA-G expressed by antigen-presenting cells or present as soluble protein down-regulates the expression of CD4 and CD8 on allostimulated T cells at both transcriptional and posttranslational levels. These CD3(+)CD4(low) and CD3(+)CD8(low) T-cell subsets are characterized by an increased proportion of cells expressing CD45RA and HLA-DR, and a decreased number of cells expressing CD62L. In addition, these HLA-G-induced CD3(+)CD4(low) and CD3(+)CD8(low) subpopulations are Foxp3-negative suppressor T cells whose function involves IL-10. Biologic relevance came from analysis of patients who underwent transplantation, with high HLA-G plasma concentrations associated with better graft survival. Peripheral blood from these patients contains increased levels of IL-10 concomitantly to an enhanced representation of CD3(+)CD4(low) and CD3(+)CD8(low) T cells compared with HLA-G-negative patients who underwent transplantation and healthy individuals. These data define novel immunosuppressive subpopulations of peripheral blood T cells induced by HLA-G with potent implications in peripheral tolerance.

摘要

HLA - G是一种具有免疫耐受原性的分子,在血清和同种异体移植组织中检测到该分子与更好的移植物接受度相关。HLA - G介导T细胞分化为抑制性细胞,据认为这些抑制性细胞可促进免疫耐受。在此,我们对外周血中此类T细胞进行了表型和功能研究,并评估了它们在接受移植患者外周血中的临床相关性。我们的结果表明,由抗原呈递细胞表达或作为可溶性蛋白存在的HLA - G在转录和翻译后水平下调同种异体刺激的T细胞上CD4和CD8的表达。这些CD3(+)CD4(low)和CD3(+)CD8(low) T细胞亚群的特征是表达CD45RA和HLA - DR的细胞比例增加,而表达CD62L的细胞数量减少。此外,这些由HLA - G诱导的CD3(+)CD4(low)和CD3(+)CD8(low)亚群是Foxp3阴性抑制性T细胞,其功能涉及IL - 10。通过对接受移植患者的分析发现了生物学相关性,高血浆HLA - G浓度与更好的移植物存活相关。与接受移植的HLA - G阴性患者和健康个体相比,这些患者外周血中IL - 10水平升高,同时CD3(+)CD4(low)和CD3(+)CD8(low) T细胞的比例增加。这些数据定义了由HLA - G诱导的外周血T细胞新型免疫抑制亚群,对外周免疫耐受具有重要意义。

相似文献

1
CD3+CD4low and CD3+CD8low are induced by HLA-G: novel human peripheral blood suppressor T-cell subsets involved in transplant acceptance.CD3+CD4低表达和CD3+CD8低表达由HLA-G诱导:参与移植耐受的新型人类外周血抑制性T细胞亚群。
Blood. 2007 Dec 1;110(12):3936-48. doi: 10.1182/blood-2007-04-083139. Epub 2007 Sep 5.
2
Alloreactive CD4+ and CD8+ T cells express the immunotolerant HLA-G molecule in mixed lymphocyte reactions: in vivo implications in transplanted patients.同种异体反应性CD4+和CD8+ T细胞在混合淋巴细胞反应中表达免疫耐受的HLA-G分子:对移植患者的体内影响
Eur J Immunol. 2004 Mar;34(3):649-660. doi: 10.1002/eji.200324266.
3
Detection of HLA-G in serum and graft biopsy associated with fewer acute rejections following combined liver-kidney transplantation: possible implications for monitoring patients.
Hum Immunol. 2003 Nov;64(11):1033-8. doi: 10.1016/j.humimm.2003.08.356.
4
Changes in peripheral blood double-negative T-lymphocyte (CD3+ CD4- CD8-) populations associated with acute cellular rejection after liver transplantation.肝移植后与急性细胞排斥反应相关的外周血双阴性T淋巴细胞(CD3+ CD4- CD8-)群体的变化。
Liver Transpl Surg. 1998 Mar;4(2):141-5. doi: 10.1002/lt.500040207.
5
HLA-G level on monocytoid dendritic cells correlates with regulatory T-cell Foxp3 expression in liver transplant tolerance.单核细胞样树突状细胞上 HLA-G 水平与肝移植耐受中的调节性 T 细胞 Foxp3 表达相关。
Transplantation. 2011 May 27;91(10):1132-40. doi: 10.1097/TP.0b013e31821414c9.
6
Observational support for an immunoregulatory role of CD3+CD4+CD25+IFN-gamma+ blood lymphocytes in kidney transplant recipients with good long-term graft outcome.对CD3 + CD4 + CD25 + IFN-γ + 血淋巴细胞在长期移植肾预后良好的肾移植受者中免疫调节作用的观察性支持。
Transpl Int. 2008 Jul;21(7):646-60. doi: 10.1111/j.1432-2277.2008.00662.x. Epub 2008 Feb 20.
7
Evidence to support the role of HLA-G5 in allograft acceptance through induction of immunosuppressive/ regulatory T cells.支持HLA-G5通过诱导免疫抑制/调节性T细胞在同种异体移植接受中发挥作用的证据。
J Immunol. 2006 Mar 1;176(5):3266-76. doi: 10.4049/jimmunol.176.5.3266.
8
Abnormal lymphocyte subsets in Kuwaiti patients with type-1 insulin-dependent diabetes mellitus and their first-degree relatives.科威特1型胰岛素依赖型糖尿病患者及其一级亲属的淋巴细胞亚群异常。
Immunol Lett. 1995 Sep;47(3):209-13. doi: 10.1016/0165-2478(95)00088-5.
9
Differential effect of pretransplant blood transfusions on immune effector and regulatory compartments in HLA-sensitized and nonsensitized recipients.移植前输血对 HLA 致敏和非致敏受者免疫效应和调节细胞亚群的差异影响。
Transplantation. 2010 Dec 15;90(11):1192-9. doi: 10.1097/tp.0b013e3181fa943d.
10
Generation of CD3+CD8low thymocytes in the HIV type 1-infected thymus.1型人类免疫缺陷病毒感染的胸腺中CD3+CD8低表达胸腺细胞的产生。
J Immunol. 2002 Sep 1;169(5):2788-96. doi: 10.4049/jimmunol.169.5.2788.

引用本文的文献

1
Increased CD8 and Decreased CD8 T Cells as Immunological Signature for Multibacilary Leprosy Patients.CD8 细胞增加和 CD8 T 细胞减少作为多菌型麻风病患者的免疫特征
Immunology. 2025 Aug;175(4):444-452. doi: 10.1111/imm.13937. Epub 2025 May 5.
2
Immunomodulatory Gene-Splicing Dysregulation in Tumorigenesis: Unmasking the Complexity.免疫调节基因剪接失调在肿瘤发生中的作用:揭示复杂性。
Molecules. 2023 Aug 10;28(16):5984. doi: 10.3390/molecules28165984.
3
An Improved Protocol for Targeted Differentiation of Primed Human Induced Pluripotent Stem Cells into HLA-G-Expressing Trophoblasts to Enable the Modeling of Placenta-Related Disorders.
一种改良的方案,可将初始人诱导多能干细胞定向分化为 HLA-G 表达的滋养层细胞,从而实现胎盘相关疾病的建模。
Cells. 2023 Aug 15;12(16):2070. doi: 10.3390/cells12162070.
4
Involvement of circulating soluble HLA-G after liver transplantation in the low immunogenicity of hepatic allograft.肝移植后循环可溶性 HLA-G 的参与导致肝移植低免疫原性。
PLoS One. 2023 Mar 10;18(3):e0282736. doi: 10.1371/journal.pone.0282736. eCollection 2023.
5
Biological Characteristics of HLA-G and Its Role in Solid Organ Transplantation.HLA-G 的生物学特性及其在实体器官移植中的作用。
Front Immunol. 2022 Jun 13;13:902093. doi: 10.3389/fimmu.2022.902093. eCollection 2022.
6
HLA-G 14bp Ins/Del Polymorphism, Plasma Level of Soluble HLA-G, and Association with IL-6/IL-10 Ratio and Survival of Glioma Patients.HLA-G 14bp插入/缺失多态性、可溶性HLA-G血浆水平及其与胶质瘤患者白细胞介素-6/白细胞介素-10比值和生存的关联
Diagnostics (Basel). 2022 Apr 27;12(5):1099. doi: 10.3390/diagnostics12051099.
7
Immunosuppressive Properties of Epidermal Keratinocytes Differ According to Their Immaturity Status.表皮角质形成细胞的免疫抑制特性与其未成熟状态有关。
Front Immunol. 2022 Feb 11;13:786859. doi: 10.3389/fimmu.2022.786859. eCollection 2022.
8
Epidemiological and histomorphic studies in sheep infected with hydatid cyst in Taif area.塔伊夫地区感染包虫囊肿绵羊的流行病学和组织形态学研究。
Saudi J Biol Sci. 2022 Feb;29(2):886-893. doi: 10.1016/j.sjbs.2021.10.017. Epub 2021 Oct 11.
9
HLA-G: Too Much or Too Little? Role in Cancer and Autoimmune Disease.HLA-G:过多还是过少?在癌症和自身免疫性疾病中的作用。
Front Immunol. 2022 Jan 27;13:796054. doi: 10.3389/fimmu.2022.796054. eCollection 2022.
10
HLA-G-ILT2 interaction contributes to suppression of bone marrow B cell proliferation in acquired aplastic anemia.HLA-G-ILT2 相互作用有助于抑制获得性再生障碍性贫血骨髓 B 细胞的增殖。
Ann Hematol. 2022 Apr;101(4):739-748. doi: 10.1007/s00277-022-04757-3. Epub 2022 Jan 18.